Qube Research & Technologies (QRT)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9,508
Closed -$1.13M 3043
2021
Q1
$1.13M Sell
9,508
-35,777
-79% -$4.23M 0.02% 806
2020
Q4
$5.35M Sell
45,285
-209
-0.5% -$24.3K 0.08% 298
2020
Q3
$5.06M Buy
45,494
+8,724
+24% +$937K 0.07% 354
2020
Q2
$3.76M Buy
36,770
+17,718
+93% +$1.9M 0.06% 450
2020
Q1
$2.06M Buy
+19,052
New +$2.19M 0.08% 226

Qube Research & Technologies (QRT)'s CBPO Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 9,508 shares — an estimated $1.13M sold.

Qube Research & Technologies (QRT) first reported a position in CBPO in Q1 2020 and held it in 5 quarters. The position peaked at $5.35M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 9,508 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $1.13M.
  • Qube Research & Technologies (QRT) first reported a position in China Biologic Products Holdings, Inc. in Q1 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s China Biologic Products Holdings, Inc. position peaked at $5.35M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.